HOB Biotech GroupLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
HOB Biotech GroupLtd has a total shareholder equity of CN¥806.0M and total debt of CN¥105.1M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are CN¥1.0B and CN¥196.8M respectively. HOB Biotech GroupLtd's EBIT is CN¥41.6M making its interest coverage ratio 35.5. It has cash and short-term investments of CN¥105.1M.
Anahtar bilgiler
13.0%
Borç/özkaynak oranı
CN¥105.05m
Borç
| Faiz karşılama oranı | 35.5x |
| Nakit | CN¥105.13m |
| Eşitlik | CN¥806.03m |
| Toplam yükümlülükler | CN¥196.80m |
| Toplam varlıklar | CN¥1.00b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08
Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 688656's short term assets (CN¥282.5M) exceed its short term liabilities (CN¥184.0M).
Uzun Vadeli Yükümlülükler: 688656's short term assets (CN¥282.5M) exceed its long term liabilities (CN¥12.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 688656 has more cash than its total debt.
Borcun Azaltılması: 688656's debt to equity ratio has reduced from 29% to 13% over the past 5 years.
Borç Kapsamı: 688656's debt is well covered by operating cash flow (102.3%).
Faiz Kapsamı: 688656's interest payments on its debt are well covered by EBIT (35.5x coverage).